Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients.
about
Risk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancersFuture directions for monitoring treatment response in colorectal cancerCurrent approaches and challenges for monitoring treatment response in colon and rectal cancerUsefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapyModern management of rectal cancer: a 2006 update.Avoiding radical surgery after pre-operative chemoradiotherapy: a possible therapeutic option in rectal cancer?Multidisciplinary treatment of rectal cancer in 2014: where are we going?The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery.Transanal endoscopic surgery in rectal cancerSystematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer.Preoperative chemoradiation and extended pelvic lymphadenectomy for rectal cancer: Two distinct principles.Neoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors.A multicentric randomized controlled trial on the impact of lengthening the interval between neoadjuvant radiochemotherapy and surgery on complete pathological response in rectal cancer (GRECCAR-6 trial): rationale and design.Adjuvant therapy for rectal cancer--the transatlantic view.Local excision for early rectal cancer: transanal endoscopic microsurgery and beyond.YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional studyPredicting tumor response after preoperative chemoradiation using clinical parameters in rectal cancer.Preoperative chemoradiation for rectal cancer: kudos and a caution.Transanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review.Response to chemoradiotherapy and lymph node involvement in locally advanced rectal cancerSystemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term SurvivalCircadian gene expression predicts patient response to neoadjuvant chemoradiation therapy for rectal cancer.Nonoperative Management or 'Watch and Wait' for Rectal Cancer with Complete Clinical Response After Neoadjuvant Chemoradiotherapy: A Critical Appraisal.Update and debate issues in surgical treatment of middle and low rectal cancer.Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.The value of forceps biopsy and core needle biopsy in prediction of pathologic complete remission in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: a cohort studyNeoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer.Utility of rectoscopy in the assessment of response to neoadjuvant treatment for locally advanced rectal cancer.Endoscopic Criteria for Evaluating Tumor Stage after Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer.Preoperative chemoradiation for locally advanced rectal cancer: comparison of three radiation dose and fractionation schedules.Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapyHow reliable is current imaging in restaging rectal cancer after neoadjuvant therapy?Degree of tumor regression after preoperative chemo-radiotherapy in locally advanced rectal cancer-Preliminary resultsTotal mesorectal excision: what are we doing?Neoadjuvant therapy followed by local excision and two-stage total mesorectal excision: a new strategy for sphincter preservation in locally advanced ultra-low rectal cancer.Current issues in locally advanced colorectal cancer treated by preoperative chemoradiotherapyInfluence of Preoperative Chemoradiotherapy on the Surgical Strategy According to the Clinical T Stage of Patients With Rectal Cancer.Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.Is the pathological regression level of metastatic lymph nodes associated with oncologic outcomes following preoperative chemoradiotherapy in rectal cancer?
P2860
Q26853016-3C01FA37-EAF3-4CCE-BC51-286B31BC7CA1Q27008428-3E24C080-B7C0-4120-9705-76D0FCCFDBFAQ27010257-95B3DD0D-07D2-413E-9E1B-A549AD1FDC69Q33787912-00E64A2A-D6B3-4C2F-87B8-5DEDA3B4F583Q33868392-C9CCBF16-DD22-4B01-ABC7-B14FBB483DC1Q34093710-74ACE322-9D58-4A6C-94DC-777E19A872BFQ34093825-2101E782-4DC0-4976-980E-12432BC63B52Q34101866-7197F9FC-AC18-4518-86AF-F98359F6EEEAQ34137260-39715636-B8D5-4BA3-96E0-C2231BD924E7Q34169310-64F5BD0B-908D-4A55-B435-2BE106BFE50AQ34391360-15598DEB-FEDA-4028-9B29-B716F1582824Q34599442-E60D4A46-5009-413E-B2BF-5535F0A6E8F7Q34985904-1436BDDE-65A3-42BA-A639-9AAE2E49BD9FQ35202155-CE915F52-52B5-4945-997E-D9FE559ED273Q35419395-6E60EE0C-E15C-4085-AFD3-96293085EA17Q35433475-550EF45E-4A57-463E-891D-BEC8072B3164Q35638806-DC8E1BA9-4B70-41C8-86E2-707E5066587DQ35767215-14164593-52A7-43B0-9AF1-06F7F8D29C48Q35931639-2792677A-25C0-455F-8562-0D91D9339B44Q36091170-3D4ECD27-770E-44E5-91E4-6D738BEAE081Q36140934-57A926C5-831D-4AA0-8E92-8C571F012D97Q36261585-0BD3060F-4F0B-4B5A-A849-6337FE450E8BQ36316710-44B001AA-7098-4086-930C-6A4AF89DCC78Q36403031-7CEE8E99-399D-4312-8992-17BD7BC27090Q36540452-3CEC0D19-B3D9-481E-BBC3-A367469139BBQ36545323-F5E7C93C-3A9E-461C-9338-2EAB6C4E5DA1Q36561777-E3A9A6AE-A71C-425A-9913-FE7AC3997B68Q36646705-088E8346-5ACC-4FFF-BEC0-D1AB7DFBA014Q36755456-E8B5C0E9-1B41-4780-9005-C4A25FF66149Q36832168-4B97DD91-01D0-4937-A7D3-7634693743BCQ37079063-1DD3767D-5EBD-4D04-9169-2EBC1FB198ECQ37106318-82A3BD45-33E6-4157-919E-9AA5850DFA4CQ37203529-EC47BC04-030A-4A23-BED5-90FB47B2EF1BQ37392500-9525CBEF-FF61-4678-A695-63BD78930D93Q37462219-4489B539-234A-4B1F-976E-4BA5F491B527Q37577559-15E7837B-8CF3-4687-8599-FBC382805096Q37602735-186F670A-6888-44FE-BB7A-D1FFBB6F9A0EQ37624231-9C2F8654-5148-4AAA-9319-338B1E586C66Q37628506-08578C78-3BE5-49C4-8E49-B4664D7804C1Q37705840-5FC0F86D-26E1-47DD-9556-6E174AA39B71
P2860
Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Assessing the predictive value ...... : an analysis of 488 patients.
@ast
Assessing the predictive value ...... : an analysis of 488 patients.
@en
Assessing the predictive value ...... : an analysis of 488 patients.
@nl
type
label
Assessing the predictive value ...... : an analysis of 488 patients.
@ast
Assessing the predictive value ...... : an analysis of 488 patients.
@en
Assessing the predictive value ...... : an analysis of 488 patients.
@nl
prefLabel
Assessing the predictive value ...... : an analysis of 488 patients.
@ast
Assessing the predictive value ...... : an analysis of 488 patients.
@en
Assessing the predictive value ...... : an analysis of 488 patients.
@nl
P2093
P1476
Assessing the predictive value ...... : an analysis of 488 patients.
@en
P2093
Alfred M Cohen
Bruce D Minsky
Jose G Guillem
Leonard B Saltz
Phillip B Paty
Raquel Wagman
Sharon M Weber
Spiros P Hiotis
W Douglas Wong
P304
131-5; discussion 135-6
P356
10.1016/S1072-7515(01)01159-0
P577
2002-02-01T00:00:00Z